Western Fjords Advanced Technologies ltd. is a private limited liability company which specializes in the development of novel therapeutic strategies based upon disease-specific induction of apoptosis.
Special emphasis is placed on the design, development and marketing of curative forms of treatment against WHO Grade II-IV Astrocytomas and other primary brain tumors.
Western Fjords Advanced Technologies ltd. has developed a working modular concept easily tailored to specifications of other diseases, thus enabling the construction of an indication-based product pipeline.
